About this Session:
Increasing uptake of biosimilars can help to drive significant cost savings and create more sustainable healthcare systems fit for the future; ensuring patients have access to a stable supply of affordable, high-quality medicines. A novel initiative in this space, Act4Biosimilars aims to increase patient access to biologic medicines by facilitating greater approvability, accessibility, acceptability and affordability through use of biosimilar medicines (the 4 A?s of biosimilars). It is supported by patient advocacy leaders, healthcare professionals, biosimilar experts and industry leaders from around the world, with a mission to increase global adoption of biosimilar medicines by at least 30% in 30+ countries by 2030. The goal is to increase access to more advanced treatment options for patients who need them, and to be part of the solution by supporting a more sustainable healthcare system for all.